Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Administration of Antenatal Magnesium Sulphate for Prevention of Cerebral Palsy and Death in Preterm Infants (MASP-STUDY)

NCT01492608 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT01492608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01492608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Administration of Antenatal Magnesium Sulphate for Prevention of Cerebral Palsy and Death in Preterm Infants (MASP-STUDY)
Lead sponsor
Hvidovre University Hospital
Phase
Phase 3
Overall status
Completed
Start date
December 16, 2011
Completion date
August 12, 2019
Enrollment
560 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy